---
title: "CTMX: Varseta-M advances in CRC and GI cancers, supported by strong cash and expanded Regeneron collaboration"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295154296.md"
description: "Varseta-M's development in CRC and other GI cancers advanced with strong clinical and operational progress, while financials reflect a robust cash position and increased R&D investment. Key milestones include a major Regeneron collaboration expansion and new executive hires.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-06T23:08:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295154296.md)
  - [en](https://longbridge.com/en/news/295154296.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295154296.md)
generator: "portal-rs"
---

# CTMX: Varseta-M advances in CRC and GI cancers, supported by strong cash and expanded Regeneron collaboration

Varseta-M's development in CRC and other GI cancers advanced with strong clinical and operational progress, while financials reflect a robust cash position and increased R&D investment. Key milestones include a major Regeneron collaboration expansion and new executive hires.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CTMX.US](https://longbridge.com/en/quote/CTMX.US.md)
- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)

## Related News & Research

- [Why Veeva Systems (VEEV) Is Up 11.6% After Strong Q2, Higher Guidance, and New AI CRM Wins](https://longbridge.com/en/news/297419205.md)
- [Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims](https://longbridge.com/en/news/296616209.md)
- [Silicon Valley wealth managers say elite tech workers are making these 5 money moves as AI mania continues](https://longbridge.com/en/news/297398623.md)
- [AI turns up a promising finding in cancer data that researchers hadn’t noticed for years](https://longbridge.com/en/news/297215988.md)
- [HAMLET.B: Advanced cancer and infection therapies reached Phase III, supported by strong R&D and financing](https://longbridge.com/en/news/297278926.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**